CRYO Stock UPDATES Cryo-Save Group N.V. (CRYO) 0.4100 08/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cryo-Save Group N.V. (CRYO) 0.4100 $CRYO

American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
GlobeNewswire - Wed Jul 02, 8:57AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has made a major step in establishing a global footprint for its cellular technology and laboratory processing platform by entering into an agreement to license its ATGRAFT(TM) adipose tissue (fat) processing and storage technologies with Health Innovative Technology Corporation Limited (HIT), a Hong Kong corporation. HIT currently operates a cellular processing and banking platform and a chain of medical centers, offering comprehensive healthcare solutions to clients in Hong Kong.

American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
GlobeNewswire - Wed Jun 18, 9:17AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has entered into initial agreements with the nanoRANCH Division of UHV Technologies, Inc. ("nanoRANCH" for the development of methods for the delivery of therapeutics and drugs focused upon cancer treatments utilizing adipose derived adult stem cells. The Company will be working with Dan Dimitrijevich, PhD to create new treatment delivery methods utilizing a combination of nanoRANCH unique technology and CRYO's clinically processed ATCELLs(TM).

Rent-A-Center, Inc. Announces Fourth Quarter and Year End 2013 Earnings Call and Webcast
GlobeNewswire - Wed Jan 15, 11:16AM CST
Rent-A-Center, Inc. (Nasdaq:RCII) today announced it will host a conference call on Tuesday, January 28, at 10:45 a.m. ET to discuss fourth-quarter results slated for release following the market's close on January 27. Live audio of the conference call will be available on the company's investor relations website at http://investor.rentacenter.com. A replay will be available beginning January 28 at 1:45 p.m. ET.

American CryoStem Posts Letter to Shareholders
GlobeNewswire - Mon Jan 06, 12:45PM CST
John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today issued a formal update in the form of a Letter to Shareholders posted to the Company's web site at www.americancryosystem.com.

Best's Rating Notification - Cincinnati Life Insurance Company
Rating Division - AMBest - Thu Dec 19, 1:14PM CST
A.M. Best Company has made the following rating update:

American Cryostem Granted Interlinked an Exclusive Interview During Recent FSXinterlinked Investment Conference
PRWeb - Tue Aug 27, 3:38AM CDT
At the recent FSXinterlinked Investment Conference, held at the Ritz Carloton in Fort Lauderdale, Florida, American Cryostem's Chairman and CEO, John Arnone, granted an exclusive interview for the FSXinterlinked channel on InterlinkedTV.

American CryoStem Granted IRB Approval for Adipose Derived Stem Cell Processing Protocols
GlobeNewswire - Wed Jul 10, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that its protocols for the processing of Stromal Vascular Fraction (SVF) and culturing of mesenchymal stem cells from autologous adipose tissue have been approved by the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).

American CryoStem to Present at OneMedForumNY 2013
GlobeNewswire - Wed Jun 26, 8:35AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has been invited to present at OneMedForumNY 2013 to be held at the Metropolitan Club in New York City, June 26-27, 2013.

Under-valued Stem Cell Innovator Targets Growing Markets
ACCESSWIRE - Wed Jun 26, 8:00AM CDT
American CryoStem (CRYO) Targets Growing End Markets

American CryoStem Welcomes Noted Cryopreservation Expert, Dr. Dayong Gao, to Medical & Scientific Advisory Board
GlobeNewswire - Mon Jun 24, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that Dayong Gao, Ph.D. has been appointed to the Company's Medical and Scientific Advisory Board.

Fat Cells Lending to New Treatments in Brain Cancer
ACCESSWIRE - Thu Jun 13, 12:30PM CDT
Regenerative medicines hold incredible potential for new, more potent therapeutics to arrive in the future for a broad spectrum of diseases and conditions. As the industry in general is growing, more possibilities are emerging seemingly on a daily basis as research uncovers new ways to use stem cells to potentially combat deadly diseases like cancer where many patients have little to no hope with today's standards of care.

American CryoStem to Present at National Investment Banking Association's 126th Investment Conference
GlobeNewswire - Tue Jun 04, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has been invited to present at the National Investment Banking Association's (NIBA) 126 Investment Conference to be held in New York City, June 17-19, 2013.

Investment Ideas in the Expanding Wound Care Market
ACCESSWIRE-TNW - Fri May 17, 10:55AM CDT
Investing in Wound Care's Real Growth Drivers

American CryoStem Partners with Rutgers for Novel Wound Care Product
ACCESSWIRE-TNW - Tue May 14, 11:01AM CDT
Regenerative medicine is constantly discovering new inroads to potential therapies utilizing adult stem cells for a variety of life threatening or debilitating conditions and diseases. Progress has accelerated in the past few years, fueled in part by President Obama's 2009 Executive Order 13505 that "removed barriers" in responsible research which has opened doors to examination of new ways of thinking. It has also aided in the emergence of research in the area of adipose (fat)-based stem cell therapy, which could prove to be a major breakthrough in regenerative medicine. Not only has early research at Johns Hopkins suggested the possibility of superior efficacy with Adipose-Derived Stem Cells, or ADSCs, in the treatment of glioblastoma (a severe form of brain cancer), but ADSCs are easily harvested, meaning that they could become a standard as the most reliable and abundant source of stem cells for research, cultures and therapeutic processes.

American CryoStem to Collaborate With Rutgers University on Adipose-Derived Stem Cell Research
GlobeNewswire - Tue May 14, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based and cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has entered into Material Transfer Agreements with three leading research scientists at Rutgers, The State University of New Jersey, distinguished as one of the world's premier universities for stem cell research and training.

The Beauty of American CryoStem Now and in the Future
ACCESSWIRE-TNW - Thu May 09, 1:12PM CDT
"What can I do with my unwanted body fat?" That is a question that is posed by American CryoStem (OTCQB: CRYO) on the home page of its website. There are plenty of finite resources in the world, but let's face it, body fat certainly isn't one of them. A little due diligence reveals the company's answer to that question, but a more discerning examination uncovers the true growth potential of American CryoStem from an immediate, mid-term and long-term perspective.

Use Your Own Stem Cells to Combat Aging Skin
ACCESSWIRE-TNW - Tue Apr 30, 5:12PM CDT
American Cryostem (OTCQB: CRYO) is a pioneer in the fields of regenerative and personalized medicine. Their multi-faceted business model involves the patented collection and storage of adipose-derived regenerative cells (ADRC's). The fat that is collected from the patient's own body can be used in cosmetic procedures like breast and buttock enhancements, which alone is a large market opportunity. However, a more intriguing proposition lies in the world of autologous, stem-cell based cosmetics treatments designed to combat the effects of aging on skin.

American CryoStem Marks Major Global Expansion Milestone: Receives First International Shipment of Adipose Tissue for Processing and Cryo-Storage From Hong Kong
GlobeNewswire - Tue Apr 23, 9:45AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receipt of its first commercial international shipment of adipose tissue for processing and long term cryo-storage.

Adipose Derived Stem Cells Providing a Bridge to the Future of Regenerative Medicine
ACCESSWIRE-TNW - Thu Apr 18, 8:54AM CDT
Regenerative medicines are finally coming into their own as validated therapies for treatment of a wide spectrum of conditions and diseases. Years of research are now behind the industry and naysayers have been silenced with compilations of data demonstrating the use of stem cells to help the body heal itself. Of course, regenerative medicine is still relatively young and a moving target with new discoveries popping up and then being reinforced. A case in point is the recent work of Johns Hopkins University School of Medicine showing that mesenchymal stem cells derived from adipose (fat) tissue might be far more efficient in the treatment of glioblastoma, the most common form of brain cancer, than those derived from bone marrow, as scientists first thought. Cells derived from fat tissue can obviously be gathered in a far less invasive - and less expensive - manner.

American CryoStem to Exhibit at The Aesthetic Meeting
GlobeNewswire - Thu Apr 11, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the field of Regenerative Medicine, today announced that the Company is scheduled to exhibit at The Aesthetic Meeting 2013, held this week, April 11-16 in New York City, at the Jacob Javits Convention Center. The Company will be showcasing its latest adipose tissue (fat) collection, processing and storage service, ATGRAFT(TM) and complimentary personalized skin care products. With one liposuction, ATGRAFT(TM) is a complete fat tissue storage solution for physicians to perform layered fat transfers and provides patients additional opportunities to use their stored fat tissue to create personalized skin care products or clinically processed stem cells for use in Regenerative Medicine treatments.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 145

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 41

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 46

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 91

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 95

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 125

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 117

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 73

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MERSCO’s Holiday Push Tests Backyard Play Demand in 2026

Updated Category News Views 22

A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 38

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
/section>

Top 5 Most Recently Viewed Articles

Unveiling Groundbreaking Research on Cenobamate at AES 2025

Updated Category News Views 163

Exciting New Developments in Epilepsy Treatment SK Life Science, Inc., a leading player in central nervous system (CNS) disorder treatments and a subsidiary of SK Biopharmaceuticals Co., Ltd., is ready to unveil ten posters featuring new research on cenobamate at the upcoming American Epilepsy Society (AES) Annual Meeting. This prestigious event will take place in...

Continue Reading
Teck Resources Unveils Strong First Quarter Earnings for 2025

Updated Category News Views 384

Teck Resources Limited Reports Impressive First Quarter Results Teck Resources Limited (NYSE: TECK, TSX: TECK.A, TSX: TECK.B) has announced its unaudited financial results for the first quarter of 2025, showcasing significant improvements over previous years. This marks a period of enhanced profitability driven by favorable market conditions. Financial Performance...

Continue Reading
Understanding Your Rights in the Symbotic Class Action

Updated Category News Views 155

Taking Action: Your Rights as an Investor in Symbotic Inc. Investors of Symbotic Inc. should be aware of a class action lawsuit initiated on their behalf. The law firm Kirby McInerney LLP is advocating for those who acquired Symbotic securities during the noted class period. This comes as a crucial reminder for shareholders to stay informed and consider their rights in...

Continue Reading
Scott Kelly Joins Worthington Steel Board, Boosting Strategy

Updated Category News Views 431

Scott Kelly Named to Worthington Steel Board Worthington Steel, Inc. (NYSE:WS), a prominent player in the metals processing industry, has officially welcomed Scott Kelly to its board of directors. This strategic appointment comes at a significant time as the company navigates its market challenges, including a recent 10% dip in stock price. Despite this, Worthington...

Continue Reading
Treasury Securities Agreements: A New Era for Primary Dealers

Updated Category News Views 232

Understanding the Latest Developments in Treasury Securities In a significant move to fortify the issuance and market making in Treasury securities, the Government Debt Management, on behalf of the Treasury, has signed crucial agreements with primary dealers. This initiative aims to ensure the Treasury’s uninterrupted access to financing while enhancing price formation...

Continue Reading